Bei Tong
Impact in
- Pharmacology top 2%
- Pharmacological Effects of Natural Compounds
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Gut microbiota and health 4
- Natural product bioactivities and synthesis 4
- Oncology 7
- Co-authors
- Yue Dai (19 shared papers)Yufeng Xia (18 shared papers)Zhifeng Wei (14 shared papers)Yannong Dou (12 shared papers)Xin Wu (8 shared papers)F. Tian (4 shared papers)Peng Zheng (4 shared papers)Bin Zheng (2 shared papers)
- Journals
- International Immunopharmacology (3 papers)PLoS ONE (2 papers)Nucleic Acids Research (2 papers)International Journal of Molecular Sciences (2 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Bei Tong
48 papers receiving 1.7k citations
Bei Tong's Hit Papers
Peers
Comparison fields: 5 of 102
- Pharmacology 169
- Infectious Diseases 247
- Complementary and alternative medicine 85
- Molecular Biology 717
- Cancer Research 139
Countries citing papers authored by Bei Tong
This map shows the geographic impact of Bei Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei Tong more than expected).
Fields of papers citing papers by Bei Tong
This network shows the impact of papers produced by Bei Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei Tong. The network helps show where Bei Tong may publish in the future.
Co-authors
The 25 scholars most cited alongside Bei Tong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2 Hit paper breakdown → | 2021 | 248 |
| 2 | 2017 | 97 | |
| 3 | 2020 | 91 | |
| 4 | 2017 | 90 | |
| 5 | 2015 | 73 | |
| 6 | 2014 | 70 | |
| 7 | 2015 | 61 | |
| 8 | 2013 | 61 | |
| 9 | 2015 | 52 | |
| 10 | 2021 | 51 | |
| 11 | 2014 | 45 | |
| 12 | 2020 | 44 | |
| 13 | 2016 | 43 | |
| 14 | 2015 | 43 | |
| 15 | 2014 | 41 | |
| 16 | Development of chitosan-carboxymethyl cellulose edible films loaded with blackberry anthocyanins and tea polyphenols and their application in beef preservation Hit paper breakdown → | 2025 | 37 |
| 17 | 2017 | 34 | |
| 18 | 2016 | 32 | |
| 19 | 2013 | 32 | |
| 20 | 2018 | 31 |
About Bei Tong
Bei Tong is a scholar working on Molecular Biology, Oncology, Pharmacology, Immunology and Cancer Research, having authored 48 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (6 papers), Immunotherapy and Immune Responses (5 papers), Gut microbiota and health (4 papers), T-cell and B-cell Immunology (4 papers), Natural product bioactivities and synthesis (4 papers), Force Microscopy Techniques and Applications (3 papers), Ginger and Zingiberaceae research (3 papers) and Phytochemicals and Antioxidant Activities (3 papers). The work is most often cited by research in Pharmacology (169 citations), Infectious Diseases (247 citations), Complementary and alternative medicine (85 citations), Molecular Biology (717 citations) and Cancer Research (139 citations). Bei Tong has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Yue Dai, Yufeng Xia, Zhifeng Wei, Yannong Dou, Xin Wu, F. Tian, Peng Zheng, Bin Zheng, Xianchi Dong and Shengchao Shi. Their work appears in journals such as International Immunopharmacology, PLoS ONE, Nucleic Acids Research, International Journal of Molecular Sciences and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.